FDA Inspection
ABBE Laboratories, Inc.ABBE Laboratories, Inc. – FDA Inspection, Sep 25, 2009
Record Details
This FDA Inspection record concerns ABBE Laboratories, Inc., with an inspection on September 25, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- ABBE Laboratories, Inc.
- Inspection Date
- September 25, 2009
- Product Type
- Drugs
View Company Profile
ID · ba120dd7-3733-41ba-a033-0e1c8314d4da
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 614146
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.130Procedures are written, and followed
- 21 CFR 211.89Quarantine of Rejected Components et. al.
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ABBE Laboratories, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2025 | OAI | New York District Office | Drug Quality Assurance |
| August 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 24, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 12, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ABBE Laboratories, Inc.
- FDA Inspection 1262223 - 2025-02-27
- FDA Inspection 1063137 - 2018-08-09
- FDA Inspection 892592 - 2014-07-24
- FDA Inspection 827113 - 2013-04-12
- FDA Inspection 783112 - 2012-05-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.